Section Arrow
CTLT.NYSE
- CATALENT
Quotes are at least 15-min delayed:2024/11/10 18:35 EST
Last
 59.41
-0.51 (-0.85%)
Day High 
59.98 
Prev. Close
59.92 
1-M High
61 
Volume 
2.57M 
Bid
58.43
Ask
60.47
Day Low
59.34 
Open
59.81 
1-M Low
58.295 
Market Cap 
10.87B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 58.99 
20-SMA 59.57 
50-SMA 60.01 
52-W High 61.2 
52-W Low 32.38 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-5.76/1.79
Enterprise Value
15.73B
Balance Sheet
Book Value Per Share
19.86
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
4.38B
Operating Revenue Per Share
24.91
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.49-0.06-3.87%-- 
ESPREsperion Therapeutics2.275+0.165+7.82%-- 
VTRSViatris12.96-0.22-1.67%227.2PE
HLNHaleon plc9.61+0.01+0.10%31.1PE
CGCCanopy Growth Corp4.24-0.31-6.81%-- 
Quotes are at least 15-min delayed:2024/11/10 18:35 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenuesprimarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.